AdvanCell, a Sydney, Australia-based clinical-stage radiopharmaceutical firm growing modern most cancers therapeutics, closed a US$112m Collection C financing.…
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
You can revoke your consent any time using the Revoke consent button.